Drugs News and Research

RSS

Olanzapine drug can help manage nausea and vomiting in patients with advanced cancer

Olanzapine, a generic drug used to treat nervous, emotional and mental conditions, also may help patients with advanced cancer successfully manage nausea and vomiting unrelated to chemotherapy.

8 May 2020

New compound significantly reduces multiple pathologies linked to Alzheimer's disease

When tested in brain cells and in a mouse model of Alzheimer's disease, a new compound significantly reduced the number of amyloid plaques in the brain, lessened brain inflammation and diminished other molecular markers of the disease.

8 May 2020

New guidelines needed to manage stroke patients during COVID-19, says neurologist

Broad modifications to current standards for treating acute stroke patients during the COVID-19 pandemic may be needed to preserve health care resources, limit disease spread and ensure optimal care, according to a Loyola Medicine neurologist.

8 May 2020

Keele University scientist urges WHO to change its official definition of osteoporosis

A Keele University academic is part of a team of researchers who are calling for the World Health Organisation (WHO) to change its official definition of the weak bone condition osteoporosis in order to increase consistency of diagnosis internationally and to also increase the uptake of treatment.

8 May 2020

Repurposing existing drugs is a more rapid alternative than developing COVID-19 vaccine

Repurposing existing medicines focused on known drug targets is likely to offer a more rapid hope of tackling COVID-19 than developing and manufacturing a vaccine, argue an international team of scientists in the British Journal of Pharmacology today.

8 May 2020

Patients do not take social media into consideration when looking for dermatologist, shows survey

Patients often do not take social media into consideration when looking for a dermatologist, according to a survey from researchers at the George Washington University. The survey was published recently in the Journal of Drugs in Dermatology.

8 May 2020

New guidance released for treating patients with osteoporosis during COVID-19 crisis

The Endocrine Society joined a coalition of leading bone health organizations to release guidance for healthcare professionals treating patients with osteoporosis in the era of COVID-19.

8 May 2020

Researchers develop safe, accurate 3D imaging method to improve IVF treatments

Tel Aviv University (TAU) researchers have developed a safe and accurate 3D imaging method to identify sperm cells moving at a high speed.

8 May 2020

A comprehensive review on therapeutic properties of plants

Nature is an amazing source for food, shelter, clothing and medicine. An impressive number of modern drugs are isolated from many sources such as plants, animals and microbes.

8 May 2020

Predicting the dose for repurposing nitazoxanide in COVID-19

A new study published on the preprint server medRxiv in May 2020 reports a model that could help evolve appropriate dosage protocols for future clinical trials of the repurposed drug nitazoxanide in COVID-19 prevention and treatment. The researchers say, “It was possible to achieve plasma and lung tizoxanide concentrations, using proven safe doses of nitazoxanide, that exceed the EC90 for SARS-CoV-2.”

7 May 2020

Vitamin D could improve outcomes in COVID-19

A new study published on the preprint server medRxiv* in May 2020 shows that vitamin D could have a beneficial effect on the course of illness for COVID-19 patients.

7 May 2020

Excluding children from COVID-19 clinical trials may limit their treatment options

A new viewpoint article from Harvard Medical School, published in the journal JAMA Pediatrics, discusses the hesitancy to include children in coronavirus disease 2019 (COVID-19) clinical trials, potentially diminishing their therapeutic options in the long run.

7 May 2020

Cholesterol lowering drugs can improve composition of gut bacteria in obese individuals

The human gut microbiota consists of trillions of bacteria, fungi and virus constituting an inner chemical factory producing a multitude of microbial compounds affecting immunity, neurobiology and metabolism of the human host.

7 May 2020

Antibiotic combined with measurement technology may save time and money in developing new active ingredients

A minimal – and therefore innocuous – dose of an antibiotic coupled with highly sensitive measurement technology could save time and money in the development of new active ingredients.

7 May 2020

Severe blood clotting and high bleeding risk identified in critically ill COVID-19 patients

Emerging data is pointing to a faulty blood clotting system in the most critically ill COVID-19 patients. Patients with underlying health problems are presenting a severe risk of VTE (blood clotting) – previously an unknown risk factor – as well as an increased bleed risk.

7 May 2020

BIOCAD becomes Vector’s industrial partner to develop COVID-19 vaccine

The biotechnology company BIOCAD has signed an agreement with the State Scientific Center for Virology and Biotechnology &laquoVektor» (Novosibirsk) on joint work on a vaccine based on rVSV against the COVID-19 virus.

7 May 2020

Arrayjet develops COVID-19 antibody screening technology to facilitate vaccine development

Arrayjet Limited, the Scottish-based bio-printing technology specialist for the life sciences industry, has re-purposed its in-house antibody screening technology to create a population-scale diagnostic program that will help scientists better understand the behavior of the Covid-19 virus and further the rapidity of a global vaccination program.

7 May 2020

Researchers discover previously unknown anti-phage defense mechanism in certain bacteria

Researchers from Singapore-MIT Alliance for Research and Technology, MIT’s research enterprise in Singapore, have discovered a new anti-phage defense mechanism found in some bacteria, which uses previously unknown features to protect their DNA.

7 May 2020

AI-enabled precision medicine may increase survival rate of patients with COVID-19-related sepsis

Data scientists from UK-headquartered AI precision medicine company, PrecisionLife, have used the Company’s proprietary AI enabled precision medicine platform to identify 59 repurposing drug candidates that could be used to develop new therapeutic strategies to increase the survival rate of patients who develop sepsis while suffering from severe COVID-19.

7 May 2020

Study discovers inhibition of SARS-CoV-2 entry priming protein by approved drug

The COVID-19 pandemic caused by the severe acute respiratory syndrome -coronavirus 2 (SARS-CoV-2) has spread to most of the world, causing millions of cases and hundreds of thousands of deaths. A new study published on the preprint server bioRxiv* shows that a protease inhibitor drug already approved by the Food and Drug Administration (FDA) could inhibit viral entry.

6 May 2020

Drugs News and Research

Olanzapine drug can help manage nausea and vomiting in patients with advanced cancer

New compound significantly reduces multiple pathologies linked to Alzheimer's disease

New guidelines needed to manage stroke patients during COVID-19, says neurologist

Keele University scientist urges WHO to change its official definition of osteoporosis

Repurposing existing drugs is a more rapid alternative than developing COVID-19 vaccine

Patients do not take social media into consideration when looking for dermatologist, shows survey

New guidance released for treating patients with osteoporosis during COVID-19 crisis

Researchers develop safe, accurate 3D imaging method to improve IVF treatments

A comprehensive review on therapeutic properties of plants

Predicting the dose for repurposing nitazoxanide in COVID-19

Vitamin D could improve outcomes in COVID-19

Excluding children from COVID-19 clinical trials may limit their treatment options

Cholesterol lowering drugs can improve composition of gut bacteria in obese individuals

Antibiotic combined with measurement technology may save time and money in developing new active ingredients

Severe blood clotting and high bleeding risk identified in critically ill COVID-19 patients

BIOCAD becomes Vector’s industrial partner to develop COVID-19 vaccine

Arrayjet develops COVID-19 antibody screening technology to facilitate vaccine development

Researchers discover previously unknown anti-phage defense mechanism in certain bacteria

AI-enabled precision medicine may increase survival rate of patients with COVID-19-related sepsis

Study discovers inhibition of SARS-CoV-2 entry priming protein by approved drug

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News